This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Warren, R Articles by Baker, A M Search for Related Content PubMed PubMed Citation Articles by Warren, R Articles by Baker, A M

 Previous Article  |  Next Article 

J Clin Microbiol. 1993 June; 31(6): 1663-1666

Comparative evaluation of detection assays for Chlamydia trachomatis.

Victorian Infectious Diseases Reference Laboratory, Fairfield Hospital, Melbourne, Australia.

ABSTRACT

The performances of a commercial nucleic acid hybridization test (Gen-Probe Pace 2 Chlamydia trachomatis) and two commercial enzyme immunoassays (EIAs) (Abbott Chlamydiazyme and Pharmacia Chlamydia EIA) were evaluated against cell culture for the detection of C. trachomatis infection, with cervical swabs obtained from 1,037 women visiting a public sexual health center. The positivity rate by cell culture was 4.7%. Sensitivity and specificity for each test were as follows: Gen-Probe, 95.8 and 98.3%; Chlamydiazyme, 80.4 and 99.3%; Pharmacia EIA, 80.8 and 99.1%. Analysis of discrepant results with probe confirmation assay (Gen-Probe) and direct immunofluorescence (Syva Microtrak) revealed 12 cases of C. trachomatis infection for which culture was negative, resulting in the definition of a true-positive case as opposed to a culture positive. The positivity rate by true-positive definition was 5.9%, and sensitivity and specificity for each test were as follows: Gen-Probe, 96.7 and 99.6%; Chlamydiazyme, 77.5 and 100%; Pharmacia EIA, 77.0 and 100%; cell culture, 80.0 and 100%. We conclude that the Gen-Probe Pace 2 C. trachomatis test is a sensitive and specific alternative to cell culture for the detection of C. trachomatis.

This article has been cited by other articles:

• Munson, E., Boyd, V., Czarnecka, J., Griep, J., Lund, B., Schaal, N., Hryciuk, J. E. (2007). Evaluation of Gen-Probe APTIMA-Based Neisseria gonorrhoeae and Chlamydia trachomatis Confirmatory Testing in a Metropolitan Setting of High Disease Prevalence. J. Clin. Microbiol. 45: 2793-2797 [Abstract] [Full Text]  
• Newhall, W. J., Johnson, R. E., DeLisle, S., Fine, D., Hadgu, A., Matsuda, B., Osmond, D., Campbell, J., Stamm, W. E. (1999). Head-to-Head Evaluation of Five Chlamydia Tests Relative to a Quality-Assured Culture Standard. J. Clin. Microbiol. 37: 681-685 [Abstract] [Full Text]  
• Wylie, J. L., Moses, S., Babcock, R., Jolly, A., Giercke, S., Hammond, G. (1998). Comparative Evaluation of Chlamydiazyme, PACE 2, and AMP-CT Assays for Detection of Chlamydia trachomatis in Endocervical Specimens. J. Clin. Microbiol. 36: 3488-3491 [Abstract] [Full Text]  
• Ferrero, D. V., Meyers, H. N., Schultz, D. E., Willis, S. A. (1998). Performance of the Gen-Probe AMPLIFIED Chlamydia Trachomatis Assay in Detecting Chlamydia trachomatis in Endocervical and Urine Specimens from Women and Urethral and Urine Specimens from Men Attending Sexually Transmitted Disease and Family Planning Clinics. J. Clin. Microbiol. 36: 3230-3233 [Abstract] [Full Text]